From Development to Market Introduction of Medical Devices

The Program Capacity Buildingprogram, led by the University Innovation Hub at the University of Montpellier, offers targeted training in innovation and research commercialization. Through thematic modules led by experts, it supports the professional development of professionals involved in innovative projects.

This one-day training session will focus on structuring a drug development plan, with an emphasis on key development stages, regulatory requirements, and creating a roadmap tailored to the expectations of health agencies. The morning will be devoted to understanding the various phases of development, while the afternoon will focus on regulatory interactions, funding mechanisms, and planning project milestones.

This session will cover the following topics:

• The stages of drug development: preclinical phases, Phase I, II, and III clinical trials;
• Regulatory issues: marketing authorization, early access, interactions with the ANSM, the EMA, and the FDA;
• Structuring a development roadmap: defining milestones, deliverables, and decision points;
• Technology Readiness Levels (TRL) and their integration into the development strategy;
• Public funding programs, including i-Lab and Horizon Europe;
• Practical examples for creating a coherent, solid, and valuable development plan.

This training is intended for individuals involved in therapeutic projects (drugs, antibodies, gene therapies) who wish to develop a robust development plan tailored to scientific, regulatory, and funding requirements.

Are you interested in this training course? Let us know by emailing Please specify your position and department.

To learn about all the modules offered by the program, consult the complete Capacity Building course catalog.